As opposed to the fast and dramatic onset of disease in the retroviral model, this system has a natural progression that is more similar to that of human CML and, thus, may provide a more physiologically relevant model for studying the events that initially follow BCR-ABL expression [42]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.